New mutations in malaria parasite encourage resistance against key preventive drug

(PLOS) In the ongoing arms race between humans and the parasite that causes malaria, Taane Clark and colleagues at the London School of Hygiene and Tropical Medicine (LSHTM) report that new mutations that enhance resistance to a drug used to prevent malaria in pregnant women and children are already common in countries fighting the disease. The new results are published Dec. 31 in PLOS Genetics.